Concepedia

Annabel McMillan

AM

Statistics

Publications

6

Citations

1.3K

H-Index

6

Active since

1992

Affiliations

University College London(Current)

Nottingham University Hospitals NHS Trust

Oxford University Hospitals NHS Trust

University College London Hospitals NHS Foundation Trust

University Hospitals Plymouth NHS Trust

Annabel McMillan is an author at University College London specializing in marrow transplantation, medicine, and cell transplantation.

ORCID

Top concepts

Publications per year

1992–2021

6

Publications

6

Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: results of a BNLI randomised trial

David C. Linch, A. H. Goldstone, Annabel McMillan et al. · The Lancet · 1993 · 1K citations

, , +9

Efficacy of R‐BAC in relapsed, refractory mantle cell lymphoma post BTK inhibitor therapy

Rory McCulloch, Carlo Visco, Toby A. Eyre et al. · British Journal of Haematology · 2020 · 68 citations · Full text

Mini‐BEAM followed by BEAM and ABMT for very poor risk Hodgkin's disease

Rajesh Chopra, David C. Linch, Annabel McMillan et al. · British Journal of Haematology · 1992 · 66 citations

Ibrutinib for mantle cell lymphoma at first relapse: a United Kingdom real‐world analysis of outcomes in 211 patients

Rory McCulloch, David Lewis, Nicola Crosbie et al. · British Journal of Haematology · 2021 · 50 citations · Full text

IVE (ifosfamide, epirubicin and etoposide) is a more effective stem cell mobilisation regimen than ICE (ifosphamide, carboplatin and etoposide) in the context of salvage therapy for lymphoma

Christopher P. Fox, Annabel McMillan, Mark Bishton et al. · British Journal of Haematology · 2008 · 16 citations · Full text

1–5 of 6